Use of MNS for pulmonary MRI at Cicinnati Children's Hospital

By Philips Featuring Jason C Woods, PhD and Yi Xia, Philips | April, 2024 | 18:35 min

Radiology

Magnetic Resonance

Webinar

MultiNuclei webinar with Dr. Woods

Webinar highlights - Total duration [18:35]

 

[01:30] ∙ Functional imaging with Xenon

[05:00] ∙ Fast imaging’s significant advantage in pediatrics

[07:35] ∙ Xenon Gas Exchange MRI

[12:04] ∙ Q&A

Join Dr. Jason C Woods in this webinar to learn how to tap into the potential of multinuclear imaging with Xenon and how Cincinnati Children’s Hospital and Philips have teamed up to explore this groundbreaking opportunity for pulmonary MRI to get high image resolution in both structural and functional imaging.

“Hyperpolarized Xenon can regionally quantify ventilation, alveolar airspace size, gas exchange parameters. Combining structure and function is powerful.”

Prof. Jason C Woods

Director of Research

Cincinnati Children’s Hospital

Cincinnati, Ohio, USA

Speakers list

Jason C Woods, PhD

Jason C Woods, PhD

Director of Research, Pulmonary Medicine,
Cincinnati Children's Hospital,
Cincinnati, Ohio, USA

Yi Xia

Yi Xia

Business Marketing Manager,
Clinical & Key Customer Relationships, Philips
Madison, Wisconsin, USA

Register for the Radiology Insights newsletter

Our periodic Radiology Insights newsletter provides you with the latest articles on user experiences and best practices.

We are always interested in engaging with you.

Let us know how we can help.

1
Select your area of interest
2
Contact details

You are about to visit a Philips global content page

Continue

You are about to visit a Philips global content page

Continue

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.

You are entering a Philips Healthcare Australia website
Please select the checkbox

The information on this site is not intended for consumers. The information is directed exclusively to health professionals, health practitioners, persons who are purchasing officers in hospitals, and persons who are engaged in the business of wholesaling therapeutic goods (as per s42AA of the Therapeutic Goods Act 1989 (Cth), and s6 of the Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021).

By clicking “Continue” you are indicating that you are one of the intended audiences. Click cancel to be redirected to the Philips website.